How Long After Taking Valtrex Are You Contagious?

Valtrex (valacyclovir) reduces your contagiousness, but it does not make you completely non-contagious at any specific point after taking it. The virus can still be transmitted even while you’re on medication, whether you’re treating an active outbreak or taking it daily as suppressive therapy. What Valtrex does is significantly lower the amount of virus your body sheds, which reduces the risk of passing it to someone else.

This isn’t the clean-cut answer most people are looking for, but understanding the timelines and risk levels can help you make informed decisions about intimacy and close contact.

How Quickly Valtrex Starts Working

After you swallow a tablet, Valtrex is rapidly absorbed and converted into its active form in your body. Within about three hours, the drug is fully at work, interfering with the virus’s ability to copy its own DNA. This essentially slams the brakes on viral replication, meaning the virus can no longer multiply efficiently in your cells.

But stopping replication is not the same as eliminating virus that’s already been produced. During an active outbreak, viral particles are already present on the skin surface and in the lesions. While Valtrex prevents the virus from making more copies, it takes time for existing virus to clear and for sores to heal. That’s why you remain contagious during an outbreak even after starting treatment.

During an Active Outbreak

If you’re treating a recurrent genital herpes outbreak, Valtrex shortens the healing window meaningfully. In clinical trials, the median time for lesions to heal was 4 days with Valtrex compared to 6 days with placebo. For cold sores (oral herpes), the average episode was about 1 day shorter on treatment.

You should consider yourself contagious for the entire duration of an outbreak, from the first tingling or prodromal sensation through complete healing of all sores. “Complete healing” means the skin has fully closed over with no visible lesion, crust, or scab remaining. Taking Valtrex gets you to that point faster, but it doesn’t create a moment during the outbreak when transmission risk drops to zero. Open or crusting sores actively shed virus, and direct skin-to-skin contact with those areas carries real transmission risk regardless of medication.

Starting Valtrex as early as possible matters. The sooner you begin treatment after symptoms appear, the faster you limit viral replication and move toward healing. Waiting even a day or two reduces how much the medication can help.

Daily Suppressive Therapy Is Different

Many people take Valtrex every day to prevent outbreaks, not just to treat them. This approach works differently and has a bigger impact on contagiousness over time. Daily suppressive therapy reduces the frequency of outbreaks by 70% to 80% in people who have frequent recurrences.

More importantly for transmission, a large study of couples where one partner had genital HSV-2 found that daily valacyclovir cut the transmission rate roughly in half. Over eight months, 3.6% of partners in the placebo group acquired the infection, compared to 1.9% in the valacyclovir group. That’s a significant reduction, but it also means transmission still happened in nearly 2 out of every 100 couples despite daily medication.

The reason transmission isn’t eliminated is asymptomatic shedding. The virus periodically reactivates and appears on the skin surface without causing any visible symptoms. This shedding happens intermittently in everyone with HSV-2, even people with longstanding infections who rarely or never have noticeable outbreaks. Valtrex reduces asymptomatic shedding substantially, but it doesn’t stop it entirely.

Why You’re Never Fully “Non-Contagious”

Herpes viruses establish permanent residence in nerve cells, where they remain in a dormant state for life. Antiviral medications like Valtrex work by blocking the virus during its active phase, when it’s replicating. They cannot reach or eliminate the dormant virus hiding in your nerves. Once you stop taking the medication, it has no lasting effect on the frequency or severity of future outbreaks or shedding.

Several factors influence how much virus you shed at any given time. Stress plays a notable role. Research on people living in isolated, high-stress environments (like Antarctic research stations) has shown that psychological stress triggers more frequent viral reactivation. Your immune system’s overall strength matters too. When T-cell function dips, whether from illness, fatigue, or other stressors, the virus has more opportunity to reactivate and shed.

Asymptomatic shedding is most frequent during the first 12 months after acquiring HSV-2. Over time, shedding episodes typically become less common, though they never disappear entirely.

Practical Ways to Lower Transmission Risk

Since there’s no specific day or hour after taking Valtrex when you become non-contagious, the most effective approach combines multiple strategies:

  • Daily suppressive therapy provides the most consistent reduction in shedding, roughly halving the chance of transmitting to a partner.
  • Avoiding contact during outbreaks is critical. From the first prodromal symptoms (tingling, itching, burning) through complete skin healing, the risk of transmission is highest.
  • Barrier protection adds another layer of risk reduction on top of medication, since shedding can occur from skin areas not covered by barriers.
  • Early treatment of outbreaks shortens the high-risk window. Starting Valtrex at the first sign of symptoms gets lesions healed in about 4 days rather than 6.

Combining daily Valtrex with barrier methods provides the greatest reduction in transmission risk, though no combination eliminates it completely.

The Bottom Line on Timing

If you’re treating an active outbreak, expect to remain contagious until all sores have fully healed, which typically takes around 4 days on Valtrex versus about 6 days without it. If you’re taking Valtrex daily for suppression, your contagiousness is lower on any given day than it would be without medication, but it never reaches zero. The virus can shed from the skin without warning, without symptoms, and without you knowing it’s happening. Valtrex is the most effective tool available for reducing that risk, but it works as a risk reducer, not an off switch.